Clinical Pathology Department, Faculty of Medicine, Mansoura University, Egypt.
BMC Endocr Disord. 2011 Aug 6;11:15. doi: 10.1186/1472-6823-11-15.
Hyperthyroidism is accompanied by osteoporosis with higher incidence of fracture rates. The present work aimed to study bone status in hyperthyroidism and to elucidate the impact of severity, duration, and etiology of hyperthyroidism on biochemical markers of bone turnover and bone mineral density (BMD).
Fifty-two male patients with hyperthyroidism, 31 with Graves' disease (GD) and 21 with toxic multinodular goiter (TNG), with an age ranging from 23 to 65 years were included, together with 25 healthy euthyroid men with matched age as a control group. In addition to full clinical examination, patients and controls were subjected to measurement of BMD using dual-energy X-ray absorptiometery scanning of the lower half of the left radius. Also, some biochemical markers of bone turnover were done for all patients and controls.
Biochemical markers of bone turnover: included serum bone specific alkaline phosphatase, osteocalcin, carboxy terminal telopeptide of type l collagen also, urinary deoxypyridinoline cross-links (DXP), urinary DXP/urinary creatinine ratio and urinary calcium/urinary creatinine ratio were significantly higher in patients with GD and TNG compared to controls (P < 0.01). However, there was non-significant difference in these parameters between GD and TNG patients (P > 0.05). BMD was significantly lower in GD and TNG compared to controls, but the Z-score of BMD at the lower half of the left radius in patients with GD (-1.7 ± 0.5 SD) was not significantly different from those with TNG (-1.6 ± 0.6 SD) (>0.05). There was significant positive correlation between free T3 and free T4 with biochemical markers of bone turnover, but negative correlation between TSH and those biochemical markers of bone turnover. The duration of the thyrotoxic state positively correlated with the assessed bone turnover markers, but it is negatively correlated with the Z-score of BMD in the studied hyperthyroid patients (r = -0.68, P < 0.0001).
Men with hyperthyroidism have significant bone loss with higher biochemical markers of bone turnover. The severity and the duration of the thyrotoxic state are directly related to the derangement of biochemical markers of bone turnover and bone loss.
甲状腺功能亢进症伴有骨质疏松症,骨折发生率较高。本研究旨在探讨甲状腺功能亢进症患者的骨状态,并阐明甲状腺功能亢进症的严重程度、持续时间和病因对骨转换生化标志物和骨密度(BMD)的影响。
纳入 52 例男性甲状腺功能亢进症患者,其中格雷夫斯病(GD)31 例,毒性多结节性甲状腺肿(TNG)21 例,年龄 23-65 岁,另选 25 例年龄匹配的健康甲状腺功能正常男性作为对照组。除全面临床检查外,患者和对照组均采用双能 X 线吸收仪对左侧桡骨下半部分进行 BMD 测量。同时,对所有患者和对照组进行骨转换生化标志物检测。
骨转换生化标志物:包括血清骨特异性碱性磷酸酶、骨钙素、I 型胶原羧基末端肽,以及尿脱氧吡啶啉交联(DXP)、尿 DXP/尿肌酐比值和尿钙/尿肌酐比值在 GD 和 TNG 患者中均显著高于对照组(P<0.01)。然而,GD 和 TNG 患者之间这些参数无显著差异(P>0.05)。GD 和 TNG 患者的 BMD 均显著低于对照组,但 GD 患者左侧桡骨下半部分 BMD 的 Z 评分(-1.7±0.5 SD)与 TNG 患者(-1.6±0.6 SD)无显著差异(>0.05)。游离 T3 和游离 T4 与骨转换生化标志物呈显著正相关,而 TSH 与这些骨转换生化标志物呈显著负相关。甲状腺毒症持续时间与评估的骨转换标志物呈正相关,但与研究中甲状腺功能亢进症患者的 BMD Z 评分呈负相关(r=-0.68,P<0.0001)。
男性甲状腺功能亢进症患者存在明显的骨丢失和较高的骨转换生化标志物。甲状腺毒症的严重程度和持续时间与骨转换生化标志物和骨丢失的紊乱直接相关。